Public Company Healthcare

OptimizeRx

Waltham, Massachusetts, United States

Technology that helps life sciences brands engage healthcare providers and patients across the healthcare journey, including AI-powered audience activation and Micro-Neighborhood technology, to deliver timely, localized experiences.

Focus Areas
Digital patient engagement, Healthcare marketing platforms, Digital therapeutics

Tracked deals

3

3 tracked deals across 2019-2023.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

3 buyout

OptimizeRx Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for OptimizeRx. 1 2019 1 2022 1 2023

Supporting Data

Recent Transactions

  • OptimizeRx Acquires Medicx Health for $95 million
    October 12, 2023
    Buyer
    OptimizeRx Corp.
    Target
    Medicx Health (Healthy Offers, Inc., dba Medicx Health)
    Industry
    Marketing & Advertising
    Location
    Arizona, United States
    Type
    Buyout

    OptimizeRx Corp. (Nasdaq: OPRX) has signed an agreement to acquire Scottsdale-based Medicx Health (Healthy Offers, Inc.) for $95 million, with certain Medicx managers rolling about $10.5 million into OptimizeRx stock. The acquisition will expand OptimizeRx's omnichannel reach by adding Medicx's patient-focused Micro-Neighborhood Targeting platform and analytics, and is expected to be immediately accretive and to increase consolidated revenue run-rate toward $100 million.

  • OptimizeRx Acquires EvinceMed Specialty Drug Market Access Platform
    March 15, 2022
    Buyer
    OptimizeRx Corporation
    Target
    EvinceMed
    Industry
    Healthcare Services
    Location
    United States
    Type
    Buyout

    OptimizeRx Corporation acquired the EvinceMed platform and related assets to integrate end-to-end automation for specialty pharmaceutical transactions into its point-of-care network. The purchase expands OptimizeRx’s capabilities for specialty drug prescribing, patient enrollment into manufacturer support programs, and point-of-dispense connectivity to improve patient access and accelerate time-to-therapy.

  • OptimizeRx Acquires RMDY Health
    September 5, 2019
    Buyer
    OptimizeRx Corporation
    Target
    RMDY Health
    Seller
    RMDY Health shareholders
    Industry
    Cloud & SaaS
    Location
    Israel
    Type
    Buyout

    OptimizeRx Corporation (NASDAQ: OPRX) agreed to acquire RMDY Health, a digital therapeutics SaaS platform, for $16 million in cash and equity ($8M cash, $8M equity). The deal expands OptimizeRx's patient engagement capabilities into digital therapeutics and adds new client segments including payers, MedTech and medical associations; RMDY will retain its technology team in Tel Aviv while U.S. personnel will operate from OptimizeRx's U.S. offices.

Related Acquisition Pages

Cloud & SaaS Buyers & Acquisitions 1 tracked deal by OptimizeRx. Healthcare Services Buyers & Acquisitions 1 tracked deal by OptimizeRx. Marketing & Advertising Buyers & Acquisitions 1 tracked deal by OptimizeRx. Acquisitions in Arizona 1 tracked deal by OptimizeRx.

Related articles

Selling a company? Get in front of buyers like OptimizeRx

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →